Randi Hagerman, MD

University of California at Davis
MIND Institute UCDH
2825 50th Street
Sacramento, , CA 95817
 
Phone: 916-703-0247
Secondary Phone: 916-703-0257
Email: [email protected]
Login to Update Your Profile
Last Updated: October 19, 2023

 

Leadership: Principal Investigator
Primary Activity Coordinators: Research
Research Director
Discipline Coordinators: Genetics
Pediatrics: Developmental/Neonatology
Psychiatry: Developmental
Specialty Resource Contacts: Director of the Fragile X Treatment and Research Center
 
Discipline(s): Medicine-Pediatrics
Medicine-Developmental-Behavioral Pediatrics
 
Research: Fragile X syndrome, premutation disorders including FXTAS, targeted treatment studies
Education: MD from Stanford Medical School
Pediatric Residency at Stanford and also at University of San Diego
Fellowship in Developmental and Behavioral Pediatrics university of California San Diego
Service: University of Colorado Director of Child Development Unit at Children's Hospital 1980-2000
Medical Director of the MIND Institute at Univ of California Davis 2000-2023

Vita/Bio

Dr. Randi Hagerman is a developmental and behavioral pediatrician and a Distinguished Professor of Pediatrics at the MIND Institute at UC Davis. She is internationally recognized as both a clinician and researcher in the field of neurodevelopmental disorders including autism and fragile X syndrome.  Dr. Hagerman received her M.D. from Stanford University, where she also carried out her Pediatric residency. She completed a Fellowship in Learning and Disabilities and Ambulatory Pediatrics at UC San Diego, then led Developmental and Behavioral Pediatrics at the University of Colorado for 20 years. She co-founded the National Fragile X Foundation in 1984. In 2000,  Hagerman joined the MIND Institute and she carries out treatment trials for  Fragile X syndrome, ASD and FXTAS.  There, she and her team discovered the Fragile X-associated Tremor/Ataxia Syndrome (FXTAS), a neurodegenerative disorder associated with the fragile X premutation.

 Hagerman has written over 500 peer-reviewed articles and numerous book chapters on neurodevelopmental disorders, as well as editing several books on fragile X disorders including a 2020 book edited by Hagerman and Hagerman titled Fragile X Syndrome and Premutation Disorders published by MacKeith press and she coedited the second edition of the Textbook of Autism Spectrum Disorders published by the American Psychiatric Publishing in 2023. Her research includes targeted treatment trials for Fragile X syndrome, autism, FXTAS and other premutation disorders.



ITAC

1100 Wayne Avenue, Suite 1000, Silver Spring, MD 20910

301-588-8252

[email protected]

This website is provided in partial fulfillment of tasks outlined in a cooperative agreement (#2 UA5MC11068-15-00) between AUCD and the Maternal and Child Health Bureau (MCHB). The contents of this website do not necessarily reflect the views or policies of MCHB, the Health Resources Services Administration (HRSA), U.S. Department of Health and Human Services, or the U.S. Government.